When was MindMaze Therapeutics founded?

MindMaze Therapeutics was founded in 2012 and raised its 1st funding round within a year of its incorporation.

Where is MindMaze Therapeutics located?

MindMaze Therapeutics is headquartered in Lausanne, Switzerland.

Who is the current CEO of MindMaze Therapeutics?

Tej Tadi and Alexandre Capet s of MindMaze Therapeutics. Tej Tadi has also founded 1 company and is an angel investors in 1 startup.

How many employees does MindMaze Therapeutics have?

As of Mar 31, 2026, the latest employee count at MindMaze Therapeutics is 90.

Is MindMaze Therapeutics a funded company?

MindMaze Therapeutics is a funded company, having raised a total of $224M across 7 funding rounds to date. The company's 1st funding round was a $10M Seed round, raised on 2012.

When was the latest funding round of MindMaze Therapeutics?

MindMaze Therapeutics' latest funding was a $105M Series B round on Feb 17, 2022, with participation from 3 investors.

Is MindMaze Therapeutics a Neurology company?

The primary sectors of MindMaze Therapeutics are Neurology and Healthcare IT.

Where does MindMaze Therapeutics rank among its competitors?

MindMaze Therapeutics ranks 375th amongst 2841 active competitors, of which 982 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Karyopharm, which secured $30M in Mar, 2026.

Who are the top competitors of MindMaze Therapeutics?

MindMaze Therapeutics' top competitors include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Among them, Karyopharm secured the most recent funding round in March, 2026.

MindMaze Therapeutics - 2026 Company Profile, Team, Funding & Competitors

MindMaze Therapeutics is a public company based in Lausanne (Switzerland), founded in 2012 by Tej Tadi. It operates as a Developer of neurotherapeutic solutions combining behavior, software, devices, and data. MindMaze Therapeutics has raised $224M in funding from Hinduja Group and Concord Health Partners. The company has 2841 active competitors, including 982 funded and 696 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Biogen and PTC Therapeutics.

Sectors and market segments that MindMaze Therapeutics operate in

MindMaze Therapeutics serves in the Life Sciences, HealthTech market segments.The primary business model of MindMaze Therapeutics are:

Company Details

Developer of neurotherapeutic solutions combining behavior, software, devices, and data. The company offers a platform for brain health and recovery. It provides precision neurotherapeutics through a portfolio of solutions. The company also develops formulations for rare diseases. Its offerings include an immersive experience platform for brain recovery and a neurorehabilitation system. It provides a hand training peripheral and technology for digital motion assessments.

Website: mindmazetherapeutics.com
Social
Email ID: *****@mindmaze.com
Phone Number: +41 **********

Key Metrics

Founded Year

2012

Location

Lausanne, Switzerland

Stage

Public

Total Funding

$224M in 7 rounds

Latest Funding Round

Series B, Feb 17, 2022, $105M

Investors

Hinduja Group & 8 more

Ranked

375^th among 2841 active competitors

Employee Count

90 as on Mar 31, 2026

Investment & Acquisitions

Neuro Motor Innovations & 1 more

Similar Companies

Jazz Pharmaceuticals & 584 more

Exit Details

Public

View MindMaze Therapeutics' full profile

MindMaze Therapeutics got listed on May 05, 2023.

Click here to take a look at MindMaze Therapeutics's IPO in detail

MindMaze Therapeutics has raised a total funding of $224M over 7 rounds. Its first funding round was on 2012. Its latest funding round was a Series B round on Feb 17, 2022 for $105M. 3 investors participated in its latest round. MindMaze Therapeutics has 8 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of MindMaze Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 17, 2022	$105M	Series B	-	-	Concord Health Partners	AlbaCore Capital Group, Salica Investments
Feb 15, 2022	$12.1M	Grant (prize money)	-	-	-	Admin
Oct 07, 2021	$125M	Conventional Debt	-	-	-	AlbaCore Capital Group

Access funding benchmarks and valuations. Sign up today!

View details of MindMaze Therapeutics's funding rounds and investors

The founders of MindMaze Therapeutics is Tej Tadi. Tej Tadi and Alexandre Capet are the CEOs of MindMaze Therapeutics.

Here are the details of MindMaze Therapeutics' key team members:

Tej Tadi: Founder & Co-CEO of MindMaze Therapeutics and founder of 2 other companies, MindMaze and MindMotion. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Alexandre Capet: Co-CEO of MindMaze Therapeutics.

MindMaze Therapeutics' Board of Directors

MindMaze Therapeutics's board has 7 active members. Meinen Jeremy, Galfetti Paolo and Hanna Walid are part of team and Stuenkel Michael, Van Beek Gregory, Blanke Olaf and Reiss Martin are independent board members.

Here is the list of MindMaze Therapeutics' board of directors:

Name	Type	Representing	Status	Duration
Meinen Jeremy	Team	-	Current	-
Galfetti Paolo	Team	-	Current	-
Hanna Walid	Team	-	Current	-
Stuenkel Michael	Independent board member	-	Current	-
Van Beek Gregory	Independent board member	-	Current	-
Blanke Olaf	Independent board member	-	Current	-
Reiss Martin	Independent board member	-	Current	-

View details of MindMaze Therapeutics's Founder profiles and Board Members

MindMaze Therapeutics' employee count trend

MindMaze Therapeutics has 90 employees as of Mar 26. Here is MindMaze Therapeutics's employee count trend over the years:

Employee count trend for MindMaze Therapeutics

Uncover MindMaze Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MindMaze Therapeutics include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Here is the list of Top 10 competitors of MindMaze Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Gershon Capital & 10 others	78/100
3rd	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 27 others	77/100
4th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating human disease conditions	$821M	Baillie Gifford, Bezos Expeditions & 17 others	75/100
5th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Nextech Invest, Third Rock Ventures & 20 others	73/100
6th	Kronos Bio 2017, San Mateo (United States), Acquired	Developer of small molecule based therapeutics for cancer treatment	$271M	Omega Funds, Vida Ventures & 18 others	72/100
7th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	Boxer Capital, BVF Partners & 15 others	72/100
8th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
9th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 18 others	72/100
10th	Karyopharm 2008, Natick (United States), Public	Developer of small molecule drugs for the treatment of cancer and inflammatory disease	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
375th	MindMaze Therapeutics 2012, Lausanne (Switzerland), Public	Developer of neurotherapeutic solutions combining behavior, software, devices, and data	$224M	AlbaCore Capital Group, Salica Investments ... & 7 others	55/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on MindMaze Therapeutics's competitors? Click here to see the top ones

MindMaze Therapeutics has acquired 2 companies including Neuro Motor Innovations and Gait Up. MindMaze Therapeutics has not made any investments as of now.

Media has covered MindMaze Therapeutics for a total of 4 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.